Has Tonia Smith received payments from drug or device companies?

Yes. Drug and device makers reported $2,303 in general payments to Tonia Smith across 103 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Tonia Smith did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Tonia Smith come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Tonia Smith

Nurse Practitioner · Fort Worth, TXNPI 1861638512

Payments from drug & device makers

$2,303in general payments, 2019–2025

Across 103 payments — averaging $22.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Alkermes, Inc.$334
AbbVie$280
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$184
Supernus Pharmaceuticals, Inc.$181
Otsuka America Pharmaceutical, Inc.$166
Takeda Pharmaceuticals U.S.A., Inc.$153
plus $1K from 16 others

What the payments were for

Food & beverage$2,25298%
Education$512%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Alkermes, Inc.	7	$334
AbbVie	19	$280
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	12	$184
Supernus Pharmaceuticals, Inc.	4	$181
Otsuka America Pharmaceutical, Inc.	9	$166
Takeda Pharmaceuticals U.S.A., Inc.	8	$153
E.r. Squibb & Sons, L.L.C.	2	$138
Validus Pharmaceuticals LLC	3	$132
Axsome Therapeutics, Inc.	4	$94
Johnson & Johnson	6	$89
Neurocrine Biosciences, Inc.	3	$73
Sunovion Pharmaceuticals Inc.	4	$68
Vanda Pharmaceuticals Inc.	4	$65
Genentech USA, Inc.	3	$61
Almatica Pharma LLC	3	$54
Jazz Pharmaceuticals Inc.	2	$47
Sanofi	2	$43
Abbott	2	$40
Corium, LLC	2	$37
Merck	2	$33
Lundbeck LLC	1	$17
Eisai Inc.	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

LYBALVI$966
QELBREE$122
COBENFY$120

How this compares

$2,303 in reported general payments places this provider in the 85th percentile of 5,422 nurse practitioner providers in Texas.

See all nurse practitioner providers in Texas →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
VraylarCariprazine Hcl	12	$16,670
Desvenlafaxine Succinate ErDesvenlafaxine Succinate	32	$4,215
Bupropion XlBupropion Hcl	83	$3,131
Duloxetine Hcl	51	$1,031
Trazodone Hcl	62	$649
Quetiapine Fumarate	37	$630
Clonazepam	83	$539
Alprazolam	89	$520
Sertraline Hcl	24	$499
Lamotrigine	25	$383
Lorazepam	29	$363
Venlafaxine Hcl ErVenlafaxine Hcl	23	$352
Escitalopram Oxalate	30	$306
Fluoxetine Hcl	26	$272
Zolpidem Tartrate ErZolpidem Tartrate	18	$181

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
AbbVieVraylar	$280	$16,67012 claims
Almatica Pharma LLCSertraline Hcl	$54	$49924 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 5,422 nurse practitioner providers in Texas.

Other nurse practitioner in Fort Worth

Deborah StapelFort Worth$44K
Jessica RothFort Worth$15K
Cecilia DavisAustin$262K
Melanie MorrisHouston$254K
Stephanie BrownHarlingen$235K
Brittney MisercolaKilleen$223K
Roger ChapmanTyler$211K
Kelly BrassilHouston$194K
Corrie BerkSan Antonio$155K
Samantha OnealDallas$133K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →